Not applicableStudy completedNCT01559636What this trial is testingDiarrhea and Bivalent Oral Polio Vaccine ImmunityWho this might be right forSeroimmunityDiarrheaPolio Centers for Disease Control and Prevention 699
Not applicableNot Yet RecruitingNCT07338851What this trial is testingThe Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L VaccinesWho this might be right forPolioMeaslesRubella+2 more China National Biotec Group Company Limited 600
Large-scale testing (Phase 3)WithdrawnNCT05166031What this trial is testingEvaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio VaccineWho this might be right forPoliomyelitis Fidec Corporation
Large-scale testing (Phase 3)Study completedNCT01813604What this trial is testingImmunogenicity of Inactivated and Live Polio VaccinesWho this might be right forPoliomyelitis Centers for Disease Control and Prevention 1,206
Large-scale testing (Phase 3)UnknownNCT04540185What this trial is testingRandomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19Who this might be right forCovid19SARS (Severe Acute Respiratory Syndrome)SARS-CoV Infection+1 more Biomed Industries, Inc. 3,600
Post-approval studies (Phase 4)Study completedNCT01633216What this trial is testingPoliovirus Vaccine Trial in BangladeshWho this might be right forHealthy Infants International Centre for Diarrhoeal Disease Research, Bangladesh 1,000
Large-scale testing (Phase 3)Study completedNCT02434770What this trial is testingImmunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis VaccineWho this might be right forPoliomyelitis PATH 750
Testing effectiveness (Phase 2)Study completedNCT03554798What this trial is testingEvaluate the Safety and Immunogenicity of Novel Oral Polio VaccineWho this might be right forPoliomyelitis Fidec Corporation 1,025
Post-approval studies (Phase 4)Study completedNCT01695798What this trial is testingIPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.Who this might be right forImmunity to Polio Vaccines in Malnourished InfantsImmunity to Polio Vaccines in Non-malnourished Infants Aga Khan University 840
Post-approval studies (Phase 4)Study completedNCT03202719What this trial is testingDuration of IPV Priming and Antibody DecayWho this might be right forPoliomyelitis Centers for Disease Control and Prevention 1,645
Post-approval studies (Phase 4)Study completedNCT01475539What this trial is testingSequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccineWho this might be right forPolioPoliomyelitis Sanofi Pasteur, a Sanofi Company 456
Post-approval studies (Phase 4)Study completedNCT02580201What this trial is testingEvaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of AgeWho this might be right forPoliomyelitis Fidec Corporation 154
Post-approval studies (Phase 4)Study completedNCT02412514What this trial is testingIntestinal and Humoral Immunity of Sequential Polio Vaccination SchedulesWho this might be right forPoliomyelitis Centers for Disease Control and Prevention 456
Post-approval studies (Phase 4)Study completedNCT03460002What this trial is testingVaccine Campaign Effects on General Hospital Admissions and Mortality Among ChildrenWho this might be right forMeasles VaccinationOral Polio VaccineNon-specific/Heterologous Effects of Vaccines+3 more Bandim Health Project 28,612
Not applicableStudy completedNCT05083039What this trial is testingObservational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19Who this might be right forCoronavirus InfectionsVaccinePolio Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products 1,500
Post-approval studies (Phase 4)Study completedNCT02907216What this trial is testingEvaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy InfantsWho this might be right forRotavirus GlaxoSmithKline 292
Large-scale testing (Phase 3)Study completedNCT02766816What this trial is testingA Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven BiologicalsWho this might be right forImmune Response to Oral Polio Vaccine Bilthoven Biologicals 1,120
Post-approval studies (Phase 4)Study completedNCT02582255What this trial is testingEvaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in LithuaniaWho this might be right forPoliomyelitis Fidec Corporation 100
Post-approval studies (Phase 4)Study completedNCT01831050What this trial is testingSafety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineWho this might be right forPoliomyelitis Fidec Corporation 1,420
Large-scale testing (Phase 3)Study completedNCT03822754What this trial is testingA Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in InfantsWho this might be right forPoliomyelitis Sinovac Biotech Co., Ltd 240